Anticoagulation With Direct Oral Anticoagulants
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Rhine PharmaGermany - Heidelberg
3 programsPoint-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1N/A1 trial
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2N/A1 trial
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants ExtendedN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Rhine PharmaPoint-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants Extended
Rhine PharmaPoint-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2
Rhine PharmaPoint-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1
Clinical Trials (3)
Total enrollment: 200 patients across 3 trials
NCT04679298Rhine PharmaPoint-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants Extended
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants Extended
Start: Jan 2021Est. completion: Aug 202380 patients
N/AUnknown
NCT02371070Rhine PharmaPoint-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2
Start: Dec 2013Est. completion: May 201660 patients
N/ACompleted
NCT02371044Rhine PharmaPoint-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1
Start: May 2013Est. completion: Sep 201460 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.